Sucampo Pharma (SCMP) Misses Q1 EPS by 17c, Reiterates FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Sucampo Pharma (SCMP) Misses Q1 EPS by 17c, Reiterates FY Guidance

Sucampo Reports First Quarter 2017 Financial Results

May 3, 2017 6:30 AM EDT

Continued Revenue Growth

Recent Vtesse Acquisition Bolsters Pipeline

Company Reiterates 2017 Guidance

Company to Host Conference Call Today at 8:30 a.m. EDT

ROCKVILLE, Md., May 03, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP), a global biopharmaceutical company, today reported consolidated financial results for the first quarter ended March 31, 2017.

... More